Business Context and Reporting Period
This Form 8-K was filed by RumbleOn, Inc. (formerly Ridenow Group, Inc.) on August 25, 2021, with the report date finalized on August 31, 2021. The filing details the entry into a material definitive agreement for a public offering of Class B Common Stock and the subsequent closing of that offering.
Key Financial Metrics and Transaction Details
- Offering Size: 4,393,939 Firm Shares plus 659,090 Additional Shares (fully exercised option), totaling 5,053,029 shares.
- Offering Price: $33.00 per share.
- Net Proceeds: Approximately $155.9 million (after underwriting discount and commission, before transaction expenses).
- Debt Repayment: $2.5 million Bridge Loan with BRF Finance Co., LLC was paid in full on August 31, 2021.
- Insider Participation: Director Denmar Dixon purchased 13,636 shares at the public price.
Material Changes and Use of Proceeds
The primary material change is the significant increase in liquidity through the equity offering. The Company intends to allocate the net proceeds as follows:
- Approximately $130 million to fund cash consideration and expenses related to the business combination with RideNow.
- Approximately $2.5 million to repay the Bridge Loan.
- Remaining funds for working capital and general corporate purposes.
Outlook, Risks, and Management Commentary
Management has confirmed the successful closing of the offering and the full exercise of the underwriters' option to purchase additional shares. The filing notes that the Underwriting Agreement contains customary representations, warranties, and indemnification obligations. No specific forward-looking financial guidance or new risk factors were disclosed in this specific filing beyond the standard terms of the underwriting agreement.
Investor Verification Checklist
- Verify the final closing date of the business combination with RideNow and the exact cash consideration amount.
- Confirm the total transaction expenses deducted from the $155.9 million net proceeds figure.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific lock-up periods or termination provisions.
- Monitor subsequent filings for the impact of the $130 million injection on the Company's balance sheet and working capital position.